vimarsana.com

Page 4 - இயற்கை மதிப்புரைகள் மருந்து கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

QuickGun LifeScience is developing a patent pending formulation as an alternative to fast track Covid-19 vaccine program

BioSilver-CEP formulation ready for testing in Adhya BioScience Lab. QuickGun LifeScience is developing a patent pending formulation as an alternative to fast track Covid-19 vaccine program ANI | Updated: Dec 11, 2020 13:04 IST New Delhi [India], December 11 (ANI/SRV Media): The need for a preventive and curative vaccine to combat the growing Covid-19 virus is the need of the hour.With over 170 countries around the world in a race to develop the first vaccine for coronavirus, researchers and scientists are treading the path, not without challenges. A critical review of vaccine technologies is as follows: Inactivated viral vaccine approach: Research was conducted on ferrets and nonhuman primates and a virus-like-particle vaccine on mice induced protection against the SARS-COV. However, the challenged animals exhibited an immunopathologic-type lung disease

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.